Thus, the mutual exclusive interaction described here provides additional independent confirmation of the relevance of the functional link between ARID1A and EGFR/MAPK-pathway during tumor progression in CRC and NSCLC patients that are EGFR signaling dependent that is consistent with previously published genetic data in NSCLC cell lines. This evidence concerns the gene EGFR and colorectal carcinoma.